Information intended for healthcare professionals only. This formulary decision guide was developed from content supplied by Novo Nordisk in a format developed by Guidelines in Practice. It has been reviewed by Novo Nordisk, who commissioned the development of the formulary decision guide.

Download the formulary decision guide

If the PDF does not load within 5 seconds, please refresh the page.

 

UK19OZM00305
Date of preparation: September 2019